Huateng Pharmaceutical, a global supplier of API intermediates, offers Carfilzomib intermediate tert-Butyl ((s)-4-methyl-1-((r)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate (CAS No.: 247068-82-2) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.
Application: An intermediate of Carfilzomib (C183460) which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
